ADAR1 Capital Management »

IDEXX Laboratories shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of IDEXX Laboratories (IDXX) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in IDEXX Laboratories

Tip: Access up to 7 years of quarterly data

All positions including IDEXX Laboratories held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in IDEXX Laboratories by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $271k 400 676.53

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Protagonist Therapeutics (PTGX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Avidity Biosciences Ord (RNA)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Cytokinetics Com New (CYTK)
Septerna (SEPN)
Arbutus Biopharma (ABUS)
Zai Lab Adr (ZLAB)
Terns Pharmaceuticals (TERN)
Cytomx Therapeutics (CTMX)
Celldex Therapeutics Com New (CLDX)
Rapt Therapeutics Com New (RAPT)

View all positions for ADAR1 Capital Management

Top funds holding IDEXX Laboratories

Vanguard Group
BlackRock
Elyxium Wealth
State Street Corporation
J. Stern & Co
Geode Capital Management
Bamco
Fundsmith
Bank of New York Mellon
Invesco
William Blair $ Company
Principal Financial Group
Polen Capital Management
Northern Trust
Jpmorgan Chase & Co

View all funds holding IDEXX Laboratories